Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2008, Pages 637-647

  Ulrich, Kristina ^a   Hincks, Jennifer S ^a   Walsh, Roddy ^a   Wetterstrand, E M Caroline ^a   Fidock, Mark D ^a   Sreckovic, Sasha ^a   Lamb, David J ^a   Douglas, Garry J ^a   Yeadon, Michael ^a   Perros Huguet, Christelle ^a   Evans, Steven M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Asthma; Corticosteroid; House dust mite; Mouse; Phosphodiesterase 4

Indexed keywords

DEXAMETHASONE; FLUTICASONE; HOUSE DUST ALLERGEN; PHOSPHODIESTERASE IV; PREDNISOLONE; ROFLUMILAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DRUG DOSE COMPARISON; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; INFLAMMATORY INFILTRATE; LONG TERM EXPOSURE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; STEROID THERAPY;

AMINOPYRIDINES; ANDROSTADIENES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BENZAMIDES; BRONCHOALVEOLAR LAVAGE; CYCLOPROPANES; DERMATOPHAGOIDES PTERONYSSINUS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; INFLAMMATION; MICE; MICE, INBRED BALB C; PHOSPHODIESTERASE INHIBITORS; PREDNISOLONE;

EID: 47049111037     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.02.006     Document Type: Article

References (55)

1. Platts M.T.A., and Wheatley L.M. The role of allergy and atopy in asthma. Curr Opin Pulm Med 2 (1996) 29-34
2. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
3. Swirski F.K., Sajic D., Robbins C.S., Gajewska B.U., Jordana M., and Stampfli M.R. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol 169 (2002) 3499-3506
4. Schramm C.M., Guernsey L., Secor E., and Thrall R.S. Tolerance induced by chronic inhaled antigen in a murine asthma model is not mediated by endotoxin. Biochim Biophys Acta 1762 (2006) 499-501
5. Swirski F.K., Sa D., Kianpour S., Inman M.D., and Stämpfli M.R. Prolonged ovalbumin exposure attenuates airway hyperresponsiveness and T cell function in mice. Int Arch Allergy Immunol 141 (2006) 130-140
6. Shinagawa K., and Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 168 (2003) 959-967
7. Leigh R., Ellis R., Wattie J., Southam D.S., de Hoogh M., Gauldie J., et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27 (2002) 526-535
8. Johnson J.R., Wiley R.E., Fattouh R., Swirski F.K., Gajewska B.U., Coyle A.J., et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Resp Crit Care Med 169 (2004) 378-385
9. Cates E.C., Gajewska B.U., Goncharova S., Alvarez D., Fattouh R., Coyle A.J., et al. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J Allergy Clin Immunol 111 (2003) 1076-1086
10. Sporik R., and Chapman M.D. Platts MTAE: house dust mite exposure as a cause of asthma. Clin Exp Allergy 22 (1992) 897-906
11. Nuttall T.J., Hill P.B., Bensignor E., and Willemse T. House dust and forage mite allergens and their role in human and canine atopic dermatitis. Vet Dermatol 17 (2006) 223-235
12. Wan H., Winton H.L., Soeller C., Taylor G.W., Gruenert D.C., Thompson P.J., et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 31 (2001) 279-294
13. Asokananthan N., Graham P.T., Stewart D.J., Bakker A.J., Eidne K.A., Thompson P.J., et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 169 (2002) 4572-4578
14. Gough L., Sewell H.F., and Shakib F. The proteolytic activity of the major dust mite allergen Der p 1 enhances the IgE antibody response to a bystander antigen. Clin Exp Allergy 31 (2001) 1594-1598
15. Gough L., Campbell E., Bayley D., Van Heeke G., and Shakib F. Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model. Clin Exp Allergy 33 (2003) 1159-1163
16. Ulrich K., Walsh R., Wetterstrand C., Hincks J., Sreckovic S., Perros-Huguet C., et al. Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model. Am J Respir Crit Care Med 175 (2007) A928
17. Bodey K.J., Semper A.E., Redington A.E., Madden J., Teran L.M., Holgate S.T., et al. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 54 (1999) 1083-1093
18. Kotsimbos T.C., Ernst P., and Hamid Q.A. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Phys 108 (1996) 368-373
19. Yuyama N., Davies D.E., Akaiwa M., Matsui K., Hamasaki Y., Suminami Y., et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19 (2002) 287-296
20. Walter D.M., McIntire J.J., Berry G., McKenzie A.N.J., Donaldson D.D., DeKruyff R.H., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167 (2001) 4668-4675
21. Tomkinson A., Duez C., Cieslewicz G., Pratt J.C., Joetham A., Shanafelt M.C., et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 166 (2001) 5792-5800
22. Hamelmann E., and Gelfand E.W. IL-5-induced airway eosinophilia-the key to asthma?. Immunol Rev 179 (2001) 182-191
23. Lindén A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 126 (2001) 179-184
24. Prause O., Bozinovski S., Anderson G.P., and Lindén A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 59 (2004) 313-317
25. Holgate S.T., Holloway J., Wilson S., Howarth P.H., Haitchi H.M., Babu S., et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 117 (2006) 496-506
26. Molimard M., Naline E., Boichot E., Devillier P., Lagente V., Bégaud B., et al. In vitro-induced human airway hyperresponsiveness to bradykinin. Eur Resp J 12 (1998) 1301-1306
27. Zhang Y., Cardell L.-O., and Adner M. IL-1beta induces murine airway 5-HT2A receptor hyperresponsiveness via a non-transcriptional MAPK-dependent mechanism. Resp Res 8 (2007) 29
28. Ritz S.A., Stampfli M.R., Davies D.E., Holgate S.T., and Jordana M. On the generation of allergic airway diseases: from GM-CSF to Kyoto. Trend Immunol 23 (2002) 396-402
29. Cates E.C., Fattouh R., Wattie J., Inman M.D., Goncharova S., Coyle A.J., et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol 173 (2004) 6384-6392
30. De Lucca G.V. Recent developments in CCR3 antagonists. Curr Opin Drug Discovery Dev 9 (2006) 516-524
31. Takizawa H. Bronchial epithelial cells in allergic reactions. Curr Drug Targets Inflamm Allergy 4 (2005) 305-311
32. Shore S.A. Direct effects of Th2 cytokines on airway smooth muscle. Curr Opin Pharmacol 4 (2004) 235-240
33. Bisset L.R., and Schmid G.P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med 11 (2005) 35-42
34. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38 (2002) 881-885
35. Ramos C.D.L., Canetti C., Souto J.T., Silva J.S., Hogaboam C.M., Ferreira S.H., et al. MIP-1{alpha}[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-{alpha} and LTB4. J Leukoc Biol 78 (2005) 167-177
36. Owen C. Chemokine receptors in airway disease: which receptors to target?. Pulm Pharmacol Ther 14 (2001) 193-202
37. Teran L.M. CCL chemokines and asthma. Immunol Today 21 (2000) 235-242
38. Romano S.J. Selectin antagonists: therapeutic potential in asthma and COPD. Treat Respir Med 4 (2005) 85-94
39. Elias J.A., Homer R.J., Hamid Q., and Lee C.G. Chitinases and chitinase-like proteins in TH2 inflammation and asthma. J Allergy Clin Immunol 116 (2005) 497-500
40. Chu H.W., Balzar S., Westcott J.Y., Trudeau J.B., Sun Y., Conrad D.J., et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32 (2002) 1558-1565
41. Ali H., and Panettieri Jr. R.A. Anaphylatoxin C3a receptors in asthma. Resp Res 6 (2005) 19
42. Matsubara S., Li G., Takeda K., Loader J.E., Pine P., Masuda E.S., et al. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness. Am J Respir Crit Care Med 173 (2006) 56-63
43. Meurs H., Hamer M.A.M., Pethe S., Vadon-Le Goff S., Boucher J.-L., and Zaagsma J. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 130 (2000) 1793-1798
44. Morcillo E.J., and Cortijo J. Mucus and MUC in asthma. Curr Opin Pulm Med 12 (2006) 1-6
45. Demedts I.K., Brusselle G.G., Bracke K.R., Vermaelen K.Y., and Pauwels R.A. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 5 (2005) 257-263
46. Blease K., Lewis A., and Raymon H.K. Emerging treatments for asthma. Expert Opin Emerg Drugs 8 (2003) 71-81
47. Nagao K., Akabane H., Masuda T., Komai M., Tanaka H., and Nagai H. Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs. J Pharm Pharmacol 56 (2004) 187-196
48. Amano T., Nishihira J., and Miki I. Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm Res 56 (2007) 24-31
49. Aoki M., Fukunaga M., Kitagawa M., Hayashi K., Morokata T., Ishikawa G., et al. Effect of a novel anti-Inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets. J Pharmacol Exp Ther 295 (2000) 1149-1155
50. Lee S.Y., Kim J.S., Lee J.M., Kwon S.S., Kim K.H., Moon H.S., et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther 21 (2008) 14-19
51. Sergejeva S., Tomaki M., Pullerits T., Zhao L.L., Johnson M., and Lotvall J. Intranasal fluticasone propionate inhibits allergen induced bone marrow eosinophilia in mice. Pulm Pharmacol Ther 15 (2002) 129-134
52. Barnes P.J. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119 (2007) 1055-1062
53. Spina D. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Drugs 63 (2003) 2575-2594
54. Kumar R.K., Herbert C., Thomas P.S., Wollin L., Beume R., Yang M., et al. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 307 (2003) 349-355
55. Deng Y.-M., Xie Q.-M., Tang H.-F., Sun J.-G., Deng J.-F., Chen J.-Q., et al. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Eur J Pharmacol 547 (2006) 125-135